Deutsche Bank Ag\ Vera Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 766,544 shares of VERA stock, worth $32.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

766,544

Previous 635,360 20.65%

Holding current value

$32.7 Million

Previous $23 Million 47.36%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$34.09 - $46.71 $4.47 Million - $6.13 Million	131,184 Added 20.65%	766,544 $33.9 Million
Q2 2024 Aug 14, 2024	SELL	$33.72 - $48.82 $55,098 - $79,771	-1,634 Reduced 0.26%	635,360 $23 Million
Q1 2024 May 15, 2024	BUY	$14.91 - $49.14 $49,337 - $162,604	3,309 Added 0.52%	636,994 $27.5 Million
Q4 2023 Feb 14, 2024	BUY	$9.29 - $16.0 $5.74 Million - $9.88 Million	617,654 Added 3852.87%	633,685 $9.75 Million
Q3 2023 Nov 09, 2023	BUY	$13.71 - $19.64 $31,382 - $44,955	2,289 Added 16.66%	16,031 $219,000
Q2 2023 Aug 14, 2023	SELL	$6.11 - $17.83 $1,270 - $3,708	-208 Reduced 1.49%	13,742 $220,000
Q1 2023 May 15, 2023	BUY	$5.41 - $18.3 $41,126 - $139,116	7,602 Added 119.75%	13,950 $108,000
Q4 2022 Feb 13, 2023	BUY	$15.74 - $22.19 $1,448 - $2,041	92 Added 1.47%	6,348 $122,000
Q3 2022 Nov 14, 2022	SELL	$13.27 - $22.31 $30,746 - $51,692	-2,317 Reduced 27.03%	6,256 $133,000
Q2 2022 Aug 11, 2022	BUY	$12.82 - $23.4 $6,012 - $10,974	469 Added 5.79%	8,573 $116,000
Q1 2022 May 13, 2022	BUY	$17.8 - $28.06 $37,219 - $58,673	2,091 Added 34.77%	8,104 $191,000
Q4 2021 Feb 11, 2022	BUY	$15.01 - $35.8 $29,194 - $69,631	1,945 Added 47.81%	6,013 $161,000
Q3 2021 Nov 04, 2021	BUY	$13.71 - $30.6 $55,772 - $124,480	4,068 New	4,068 $71,000

Others Institutions Holding VERA

# of Institutions

184

Shares Held

55.1M

Call Options Held

134K

Put Options Held

156K

View Full List

About Vera Therapeutics, Inc.

Ticker VERA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,042,300
Market Cap $1.15B
Description
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...

More about VERA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account